Get access
Clinical & Experimental Allergy

Effects of inhaled ciclesonide on circulating T-helper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge

Authors


Correspondence:
Dr Gail M. Gauvreau, Department of Medicine, Health Sciences Centre, McMaster University, Room 3U25, 1200 Main St. W, Hamilton, ON L8N 3Z5, Canada.
E-mail: gauvreau@mcmaster.ca

Summary

Background The predominance of T-helper type 2 (Th2) lymphocytes is thought to underlie the pathogenesis of asthma. Allergen inhalation challenge in atopic asthmatic subjects is associated with decreased interferon-γ (IFN-γ) positive CD4+ and CD8+ lymphocytes in peripheral blood and induced sputum.

Objective This study examined the effects of an inhaled corticosteroid on these previously described allergen-induced changes in circulating Th1 and Th2 lymphocytes.

Methods Subjects were randomized to 7 days of placebo, 40 or 80 μg ciclesonide in a crossover study. Airway responses and peripheral blood were measured before and after treatment, and 24 h after allergen challenge.

Results Ciclesonide 40 and 80 μg significantly attenuated the late response and sputum eosinophils at 8 h post-allergen (P<0.05). Circulating IFN-γ positive CD4+ lymphocytes decreased after allergen challenge with placebo (P<0.05), and this was inhibited by 40 μg ciclesonide treatment (P<0.05). There was no effect of allergen inhalation or ciclesonide on IL-4-positive CD4+ lymphocytes or IFN-γ and IL-4-positive CD8high lymphocytes. The allergen-induced change of IFN-γ/IL-4 ratio on CD4+ cells correlated with the allergen-induced change of peripheral blood eosinophils.

Conclusions The results of this study suggest that attenuation of allergen-induced airway responses by ciclesonide may be mediated through regulation of IFN-γ-positive CD4+ cells.

Get access to the full text of this article

Ancillary